SCHEMBL560858

SCHEMBL560858

[CH2]c1cnc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28244449 0.97
SCHEMBL7194641 0.67 IDO1 (0.59)
SCHEMBL27797065 0.65
SCHEMBL128969 0.63
SCHEMBL9601465 0.63
SCHEMBL11469460 0.63
SCHEMBL72511 0.62
SCHEMBL834961 0.62
SCHEMBL2004949 0.62
Ammonia Solution, Strong SCHEMBL28242555 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 699 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118102889-A Organic compound 奇华顿股份有限公司 2024-05-28 CN claimed
CN-118055943-A Cyclic peptide antibiotics 基因泰克公司 2024-05-17 CN claimed
US-20240116952-A1 KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-04-11 US claimed
EP-4347618-A1 CYCLIC PEPTIDE ANTIBIOTICS Genentech, Inc. (US) 2024-04-10 EP claimed
WO-2024050640-A1 4-(3,8-DIAZABICYCLO[3.2.1]OCTAN-3-YL)PYRIDO[4,3-D]PYRIMIDINES AND USE THEREOF AS KRAS INHIBITORS Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-03-14 WO claimed
CN-117164605-A KRAS G12D inhibitors and related uses thereof 润佳(苏州)医药科技有限公司 2023-12-05 CN claimed
EP-3570897-B1 RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES THERAPHARM GMBH (CH) 2023-10-04 EP claimed
CN-116284055-A KRAS inhibitor and application thereof 润佳(苏州)医药科技有限公司 2023-06-23 CN claimed
CN-115785124-A KRAS G12D inhibitors and uses thereof 润佳(苏州)医药科技有限公司 2023-03-14 CN claimed
CN-115721742-A Radioactive immunoconjugates and their use for bone marrow pretreatment or treatment of bone marrow related diseases 塞拉法尔目有限责任公司 2023-03-03 CN claimed
CN-1082547-A Azabicyclic compounds FUJISAWA PHARMACEUTICAL CO (JP) 1994-02-23 CN claimed
WO-1993021186-A1 SUBSTITUTED 3-PYRROLIDINYLTHIO-CARBAPENEMS AS ANTIMICROBIAL AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-10-28 WO claimed
EP-0528035-A1 POLYELECTROLYTE COMPLEX ANTIBACTERIAL AGENT AND ANTIBACTERIAL MATERIAL IATRON LABORATORIES, INC. (JP) 1993-02-24 EP claimed
EP-0381959-A1 Cyclohexaneacetamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 1990-08-16 EP claimed
US-4927964-A Method for production of 2-oxyimino-3-oxobutyric acids TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-05-22 US claimed
CN-1038637-A The preparation method of 2-oxidation imino--3-ketobutyric acid TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1990-01-10 CN claimed
EP-0325183-A2 Method for the production of 2-oxyimino-3-oxobutyric acids Takeda Chemical Industries, Ltd. (JP) 1989-07-26 EP claimed
EP-0192976-B1 COMPOUNDS HAVING ANTIHYPERLIPEMIC ACTIVITY, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) 1989-06-14 EP claimed
EP-0077460-B1 PURINE COMPOUNDS ENDOWED WITH IMMUNOMODULATING ACTIVITY CO PHARMA CORPORATION S.r.l. (IT) 1986-10-15 EP claimed
EP-0192976-A1 Compounds having antihyperlipemic activity, processes for the preparation thereof and pharmaceutical compositions containing them BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) 1986-09-03 EP claimed